Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Immupharma Share Price
  4. Immupharma Share Regulatory News
  5. Annual Report and Accounts

Pin to quick picksImmupharma Regulatory News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.405    0.00 (0.00%)
Bid:
4.405
Ask:
4.58
Spread: 0.175 (3.973%)
Market Cap: £27.48m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Annual Report and Accounts

30 Jun 2009 07:00

RNS Number : 7193U
Immupharma PLC
30 June 2009
Β 

ο»Ώ

For Immediate Release

30 June 2009

ImmuPharma PLC

Β 

Annual Report and Accounts

Β 

Β 

In accordance withΒ Rule 20Β of the AIM Rules,Β ImmuPharma PLC (AIM:IMM),Β the specialist drug discovery and development company,Β confirms that the Annual Report and Accounts for the year ended 31 December 2008,Β hasΒ beenΒ posted toΒ shareholders.Β 

The annual report is available, in electronic form, for download on the Company's websiteΒ www.immupharma.com.Β 

The Company's Annual General Meeting will be held on 24 July 2009 at 11am at 50 Broadway, London, SW1H 0BL.

Β 

Ends

For further information please contact:Β 

ImmuPharma PLC:Β 

Dimitri Dimitriou, Chief Executive Officer

+44 20 7152 4080

Richard Warr, Chairman

+44 20 7152 4080

Buchanan Communications

+ 44 20 7466 5000

Lisa Baderoon

Rebecca Skye Dietrich

Panmure Gordon & Co

Andrew Burnett

+44 151 243 0963

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACSFLMFTMMMTBPL
12345678910
Date   Source Headline
4th Jun 20267:10 amRNS-RIncanthera plc – Corporate Update & Board Changes
2nd Jun 20267:00 amRNSNotice of AGM & Annual Report & Accounts
27th May 20267:00 amRNSFinal Results
5th May 20267:00 amRNSIMM initiatesIND-Enabling Program for Kapiglucagon
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNS-RChairman’s Open Letter to Shareholders
7th Apr 202611:45 amRNSResult of General Meeting and TVR
27th Mar 20267:00 amRNSP140 Program Update
23rd Mar 20267:00 amRNSResult of WRAP Retail Offer and TVR
19th Mar 20269:00 amRNSPublication of Circular
18th Mar 20267:00 amRNS-R‘Investor Meet Company’ presentation on 20 March
17th Mar 20267:01 amRNSWRAP Retail Offer for up to £1.5 million
17th Mar 20267:01 amRNSWRAP Retail Offer for up to £1.5 million
17th Mar 20267:00 amRNSP140 Update; Fundraise, Related Party Transaction
17th Mar 20267:00 amRNSP140 Update; Fundraise, Related Party Transaction
6th Jan 20264:11 pmRNSHolding(s) in Company
6th Jan 20267:00 amRNS-RAttending JPMorgan Conference & Biotech Showcase
24th Nov 20257:00 amRNSCorporate Update
4th Nov 20257:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RIMMUPHARMA ATTENDING BIO-EUROPE
23rd Oct 20257:00 amRNSLaunch of Website; Corporate Update
13th Oct 20257:00 amRNSAppointment of Independent Non-Executive Director
6th Oct 20253:22 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSExercise of Warrants
11th Sep 20257:00 amRNSExercise of Warrants
1st Sep 20252:12 pmRNSAppointments of CSO and Head of R&D
1st Sep 20251:20 pmRNSImmuPharma Files New Patent Application for P140:
20th Aug 20251:36 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSInterim Results
12th Jun 202512:51 pmRNSResult of AGM
27th May 20253:13 pmRNSHolding(s) in Company
20th May 20257:00 amRNSNotice of AGM
19th May 20257:00 amRNSFinal Results
1st Apr 20257:00 amRNSWarrant Extension, Debt Conversion & Equity Issue
1st Apr 20257:00 amRNSExtension of Warrants in Incanthera to 30 Sep 2025
14th Mar 20257:00 amRNS-RIMM attending Bio-Europe Spring 17-19 March,Milan
13th Mar 20257:00 amRNSImmuPharma proves unique Mechanism of Action-P140
21st Feb 202511:36 amRNSHolding(s) in Company
13th Feb 20257:00 amRNS£2.91m fundraising; related party transactions
28th Jan 202512:57 pmRNSResponse to Share Price Movement
9th Jan 20257:00 amRNSBreakthrough Findings into Autoimmune Diseases
23rd Dec 20247:00 amRNSChange of Auditor
10th Dec 20242:36 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNSAppointment of Company Secretary
9th Sep 20247:01 amRNSExtension of Warrants in Incanthera to 31 Mar 2025
9th Sep 20247:00 amRNSHalf-year Report
6th Aug 20241:41 pmRNSHolding(s) in Company
28th Jun 202412:17 pmRNSResult of AGM
6th Jun 20244:20 pmRNSHolding(s) in Company
5th Jun 20242:01 pmRNSNotice of AGM & Annual Report & Accounts
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MSLH
Marshalls
LSE
-0.42%
SAB
SAB.L
LSE
0.00%
EQN
EQN.L
LSE
0.00%
MERL
Merlin Entertainments
LSE
0.00%
Trending
LLOY
Lloyds
LSE
-0.90%
KEFI
Kefi Gold & Copper
LSE
-4.23%
GGP
Greatland Resources
LSE
-2.84%
80M
80 Mile
LSE
8.21%
IMM
Immupharma
LSE
0.00%